Sexual and Gender Minorities' Vaccine Uptake and Behavioral Change in Response to the Mpox Outbreak in the United States: August 2022 Through November 2022.

Grov, Christian; Zohra, Fatima; Mirzayi, Chloe; Stief, Matthew; D'Angelo, Alexa B; Dearolf, Michelle; Westmoreland, Drew A; Carneiro, Pedro; Nash, Denis; Carrico, Adam W

Grov, Christian; Zohra, Fatima; Mirzayi, Chloe; Stief, Matthew; D'Angelo, Alexa B; Dearolf, Michelle; Westmoreland, Drew A; Carneiro, Pedro; Nash, Denis; Carrico, Adam W.

Afiliación

Grov C; Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
Zohra F; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
Mirzayi C; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
Stief M; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
D'Angelo AB; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
Dearolf M; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
Westmoreland DA; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.
Carneiro P; Department of Epidemiology, College of Public Health and Health Professions, University of Florida, Gainesville, Florida, USA.
Nash D; Department of Community Health and Social Sciences, CUNY Graduate School of Public Health and Health Policy, New York, New York, USA.
Carrico AW; CUNY Institute for Implementation Science in Population Health, New York, New York, USA.

Clin Infect Dis ; 2024 Jan 23.

Article en En | MEDLINE | ID: mdl-38262167

ABSTRACT

ABSTRACT

BACKGROUND:

In the summer of 2022, the United States faced a nationwide outbreak of mpox, with cases concentrated in sexual and gender minorities who have sex with men. Understanding rates of mpox vaccine uptake and concomitant behavioral change is essential to guide the implementation of targeted public health responses to the potential reemergence of mpox.

METHODS:

Between August 2022 and November 2022, 8551 individuals recruited via geosocial networking apps completed a brief survey that assessed mpox vaccine uptake, intentions to get a mpox vaccine, and behavioral change.

RESULTS:

In August, 17.4% of participants reported having received at least 1 dose of the mpox vaccine. By November, this prevalence estimate was 35.0%. Black participants were significantly less likely to be vaccinated, and vaccine hesitancy increased among Black participants over time. Among those who had not yet received a vaccination, the intention to get vaccinated decreased over time. We observed trends that coincided with the evolving outbreak, such as decreased worry about mpox and less engagement in risk reduction behaviors over time.

CONCLUSIONS:

Despite a 2-fold increase in mpox vaccine uptake between August 2022 and November 2022 in sexual and gender minorities who have sex with men, disparities in vaccine uptake were observed among Black participants. Findings will guide the implementation of public health responses to the potential reemergence of mpox and other viral infectious diseases (eg, meningitis) with a specific focus on optimizing vaccine uptake in Black communities.

Palabras clave

gender and sexual minorities; mpox; risk reduction; vaccine uptake

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Qualitative_research / Risk_factors_studies Aspecto: Determinantes_sociais_saude Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google